Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Kiora Pharmaceuticals, Inc. (KPRX) had Normalized Pre-Tax Income of $-0.62M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$0.03M |
|
-- |
|
-- |
|
$0.79M |
|
$-0.79M |
|
$0.18M |
|
$-0.62M |
|
|
Normalized Pre-Tax Income |
$-0.62M |
$0.03M |
|
$0.03M |
|
$0.03M |
|
$0.03M |
|
$-0.79M |
|
$-0.78M |
|
4.23M |
|
4.36M |
|
$0.01 |
|
$0.01 |
|
| Balance Sheet Financials | |
$22.69M |
|
$0.10M |
|
$7.17M |
|
$29.86M |
|
$2.58M |
|
-- |
|
$4.87M |
|
$7.45M |
|
$22.41M |
|
$15.72M |
|
$22.41M |
|
3.43M |
|
| Cash Flow Statement Financials | |
$-7.78M |
|
$9.08M |
|
$0.27M |
|
$3.80M |
|
$5.51M |
|
$1.72M |
|
$0.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.81M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
0.12% |
|
0.17% |
|
0.09% |
|
0.12% |
|
$6.53 |
|
$-1.79 |
|
$-1.78 |
|